Now on its third PE owner, Guardian Early Learning Group is building its unique brand identity in Australia’s busy childcare sector. The key has been for each party to respect the strengths and needs of the other
Bolt-on acquisitions enable private equity firms to bring down the cost of investments through multiple arbitrage and leveraging synergies. But in a climate of heady valuations, are GPs thinking too big?
A consortium headed by two Korean private equity firms and supported by domestic steelmaker Posco has been selected as the preferred bidder for distressed Australian mining and minerals giant Arrium.
Sapphire Ventures has led a $20 million Series C funding round for Australian business analytics services provider Culture Amp.
Blue Star Sports, a US-based company controlled by Genstar Capital that provides management software to grassroots sports clubs, has entered the Australia and New Zealand market with the acquisition of SportsTG.
Australian digital marketing services company Rokt has closed a Series B funding round at $26 million led by Moelis Australia Asset Management.
The Carlyle Group and Pacific Equity Partners (PEP) have finalized an agreement to jointly acquire Australia-based iNova Pharmaceuticals for $930 million in cash.
Blackbird Ventures has led a $12 million round for Sydney and San Francisco-based marketing software provider Autopilot.
IP Group has built a business in the UK and US working with universities to turn academic ideas into investable business models. It has now raised $149 million for expansion in Australia and New Zealand
KKR has offered to acquire Vocus Group, one of Australia's leading high-speed broadband internet providers, in a deal worth approximately A$2.1 billion ($1.6 billion).
Australian VC investors Brandon Capital and Uniseed have committed $16 million to Que Oncology, a clinical-stage drug development company established by the University of Queensland (UQ) and US-based Emory University.
Australia’s OneVentures has invested A$10 million ($7.4 million) in Prota Therapeutics, a domestic immunotherapy technology developer aiming to commercialize new peanut allergy treatments for children.
Camp Australia, an outside school hours care provider acquired by Bain Capital Private Equity in February, has agreed to merge with Junior Adventures Group (JAG), a similar business controlled by Advent Partners.
Quadrant Private Equity agrees a $746 million exit from Icon Group, with new owners QIC, Goldman Sachs and Pagoda Investment keen to continue the cancer specialist's expansion in Asia
IP Group, which specializes in commercializing intellectual property, has raised a new round of funding from investors including Temasek Holdings and Telstra Super, and pledged to invest A$200 million ($149 million) in Australia and New Zealand.
Australia’s growing technology sector is set to benefit from long-term socioeconomic trends in Asia. Success will depend on both operational tenacity and a fundamental shift in expansion philosophy
Action Potential Venture Capital (APVC), an investment arm of British pharmaceutical company GlaxoSmithKline, has led a A$53 million ($40 million) all-equity Series D round for Australia’s Saluda Medical.
Malaysian telecommunications conglomerate Axiata has led a $23 million investment in early-stage Australian advertising technology company Unlockd.
Navis Capital Partners has agreed to sell its controlling stake in Australia’s Retail Apparel Group (RAG) to The Foschini Group of South Africa in a deal worth A$302.5 million ($225 million).
Australian venture capital firm Artesian Venture Partners has raised A$26 million ($19.5 million) for a domestic clean energy fund with a A$10 million cornerstone investment from the government’s A$1 billion Clean Energy Innovation Fund.
CITIC Capital China has joined a consortium including China’s Humanwell Healthcare to acquire the sexual health division of Australia-listed medical products supplier Ansell for $600 million.
CHAMP Private Equity has reached a final close of A$735 million ($547 million) on its fourth Australia and New Zealand-focused fund.
Blue Sky Alternative Investors will exit its stake in HPS, Australia’s largest provider of outsourced pharmacy services to hospitals, as healthcare business EBOS agreed to buy the asset for A$154 million ($116 million).